# A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso

> **NCT01635647** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 730 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** ChAd63 ME-TRAP and MVA ME-TRAP
- **BIOLOGICAL:** Rabies vaccine

## Key facts

- **NCT ID:** NCT01635647
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 730 (ACTUAL)
- **Last updated:** 2016-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635647, "A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01635647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*